According to a report by the U.K. BioIndustry Association (BIA) and insights company Clarivate, low appetite from investors meant biotech IPOs only brought in a combined total of 28 million pounds sterling ($35 million), the lowest haul since 2012. Source: Fierce Biotech 27/1/2023